Hyoscine Butylbromide Global Buyers List: Verified International Importers & Market Insights

Hyoscine Butylbromide, also widely known as Butylscopolamine Bromide, is a critical antispasmodic pharmaceutical API (Active Pharmaceutical Ingredient) and finished drug formulation used globally to treat gastrointestinal spasms, abdominal pain, and smooth muscle contractions. As a high-demand specialty pharma chemical, it maintains steady cross-border trade volume across pharmaceutical manufacturing, drug distribution, and medical supply industries worldwide.

For API manufacturers, pharmaceutical exporters, and B2B pharma traders, accessing a credible Hyoscine Butylbromide global buyers list is essential for expanding international market reach, establishing long-term procurement partnerships, and minimizing trade risks. This comprehensive guide compiles verified global importers, core regional buyer markets, key buyer categories, and actionable trade insights to support targeted B2B outreach and sustainable business growth.

Core Overview of Global Hyoscine Butylbromide Import Market

The global Hyoscine Butylbromide trade ecosystem is dominated by pharmaceutical enterprises, licensed drug distributors, and medical raw material procurement firms. Unlike general chemical products, Hyoscine Butylbromide trade requires strict compliance with regional pharmaceutical regulatory standards, including GMP, FDA, and EU GMP certifications, making verified professional buyers the primary participants in cross-border transactions.

Regional import data shows concentrated demand across Asia, Southeast Asia, Europe, and Latin America. Emerging markets demonstrate growing consumption demand, while mature pharmaceutical markets maintain stable repeated procurement needs for both API raw materials and finished tablet/injection formulations. The industry’s standardized HS code classification ensures transparent cross-border customs clearance and consistent trade data statistics for global buyers and sellers.

Verified Regional Hyoscine Butylbromide Global Buyers List & Key Importers

Below is a categorized, verified list of active global Hyoscine Butylbromide buyers, segmented by major regional markets, covering top pharmaceutical importers, raw material procurement companies, and licensed drug distributors with consistent import records.

1. Asian Market Key Buyers (Largest Global Import Region)

Asia ranks as the top importing region for Hyoscine Butylbromide, driven by robust generic pharmaceutical manufacturing and massive domestic medical demand. India, Singapore, and Seychelles lead regional import volumes, with continuous bulk procurement of API and finished formulations.

• Dr. Reddy’s Laboratories (India): A leading Indian pharmaceutical enterprise specializing in the import of high-purity Hyoscine Butylbromide API for generic drug formulation production, with long-term cross-border procurement channels across Asia and Europe.
• Sun Pharmaceutical Industries (India): A top global generic drug manufacturer, regularly importing pharmaceutical-grade Hyoscine Butylbromide raw materials for antispasmodic drug production and regional distribution.
• Cipla Inc. (India): Specializes in the procurement of compliant Hyoscine Butylbromide formulations and APIs for domestic medical supply and South Asian market distribution.
• Regional Singapore-based Pharma Distributors: Multiple licensed pharmaceutical trading firms in Singapore act as regional transit buyers, importing Hyoscine Butylbromide for redistribution to Southeast Asian and Oceanian markets.

2. European Market Professional Buyers

European buyers prioritize high-purity, fully regulated Hyoscine Butylbromide products that meet EU pharmaceutical standards. Most European importers are well-established pharmaceutical giants and specialized medical raw material trading companies with strict quality verification systems.

• Boehringer Ingelheim (Germany): A global pharmaceutical leader with stable procurement demand for premium Hyoscine Butylbromide APIs and finished formulations for European medical markets.
• Transo-Pharm Handels GmbH (Germany): A professional European pharmaceutical raw material trading company, focusing on the import and wholesale of certified Hyoscine Butylbromide API for regional manufacturers.
• Tenatra Chemie (Europe): Specializes in specialty pharma chemical imports, including pharmaceutical-grade Butylscopolamine Bromide for industrial drug production.

3. Middle Eastern & African Market Buyers

Middle Eastern and African markets feature growing demand for affordable, compliant Hyoscine Butylbromide finished drugs and APIs. Local licensed medical distributors and pharmaceutical manufacturing enterprises are the core active buyers.

• Aspen API (South Africa): A leading African pharmaceutical manufacturer, importing standardized Hyoscine Butylbromide raw materials for domestic generic drug production and Southern African market coverage.
• Regional Gulf Pharma Distributors: Licensed medical supply enterprises in UAE, Saudi Arabia, and Qatar with regular import demand for finished Hyoscine Butylbromide formulations for hospital and pharmacy distribution.

4. Latin American Market Core Importers

Latin American buyers focus on cost-effective, regulatory-compliant Hyoscine Butylbromide products, with Mexico, Brazil, and Argentina as key import hubs. Local pharmaceutical distributors dominate cross-border procurement.

• SIGMA ALDRICH QUIMICA S.A. DE C.V. (Mexico): A major regional chemical and pharmaceutical raw material importer, sourcing high-quality Hyoscine Butylbromide API for local industrial and medical applications.
• CHEMO SA DE CV (Mexico): Specializes in the import and distribution of specialty pharma chemicals, including Butylscopolamine Bromide for Latin American pharmaceutical manufacturers.
• BOEHRINGER INGELHEIM MEXICO: Regional branch procurement team responsible for importing standardized Hyoscine Butylbromide formulations for local medical market supply.

5. Global Multinational Pharmaceutical Buyers

International pharmaceutical groups maintain global procurement networks for Hyoscine Butylbromide, ensuring stable supply chains for their worldwide drug distribution businesses.

• Sanofi S.A.: Global pharmaceutical giant with cross-border procurement demand for certified Hyoscine Butylbromide APIs and finished drugs.
• Teva Pharmaceutical Industries (Israel): A top generic drug manufacturer, importing pharma-grade Butylscopolamine Bromide for global formulation production.
• Abbott Laboratories: Procures compliant Hyoscine Butylbromide products for global medical and pharmaceutical supply chains.

Key Categories of Global Hyoscine Butylbromide Buyers

Understanding buyer categories helps exporters conduct precise market positioning and targeted B2B marketing. Global Hyoscine Butylbromide buyers fall into three core categories:

1. Pharmaceutical API Manufacturers

These enterprises purchase high-purity Hyoscine Butylbromide raw materials for secondary purification, formulation processing, and finished drug production. They prioritize product purity certificates, GMP compliance, batch stability, and long-term supply capacity, with large-volume, repeat procurement demands.

2. Licensed Pharma Distributors & Traders

Professional pharmaceutical trading companies and regional distributors import bulk Hyoscine Butylbromide APIs or finished formulations for secondary sales to local manufacturers, hospitals, and pharmacy chains. They focus on competitive pricing, complete certification documents, and flexible shipping terms.

3. Medical Institution Procurement Organizations

Hospital procurement departments and public medical supply agencies mainly purchase finished Hyoscine Butylbromide tablets and injections for clinical medical use, requiring strict drug registration certification and batch safety inspection reports.

Critical Factors Global Hyoscine Butylbromide Buyers Prioritize

To successfully cooperate with international buyers, exporters must align with core buyer evaluation criteria, which define long-term B2B partnership opportunities:

• Regulatory Compliance: Buyers require full compliance with regional pharmaceutical standards, including GMP, ISO, FDA, and EU certification, with complete batch test reports and safety documents.
• Product Purity & Stability: Pharmaceutical-grade Hyoscine Butylbromide requires high purity, low impurity content, and stable chemical properties to meet drug formulation standards.
• Supply Chain Reliability: Global buyers prioritize suppliers with stable production capacity, on-time delivery, and flexible bulk order support to avoid supply chain disruptions.
• Competitive Pricing & Customization: Balanced cost performance and customizable packaging, batch specifications, and documentation services attract long-term distributor buyers.

Tips for Connecting With Global Hyoscine Butylbromide Buyers

For pharmaceutical exporters seeking to expand global business with Hyoscine Butylbromide buyers, the following actionable strategies optimize B2B conversion efficiency:

First, verify buyer authenticity through professional global trade databases to avoid invalid or low-quality customer resources, focusing on enterprises with continuous import records and formal pharmaceutical qualifications. Second, prepare complete certification documents, including product COA, GMP certificates, and customs clearance materials, to meet international trade compliance requirements.

Third, conduct regional market segmentation: provide high-certification premium products for European and American markets, and cost-effective compliant products for Southeast Asian, African, and Latin American markets. Finally, establish long-term after-sales and supply stability mechanisms to build sustainable cooperative relationships with repeated-purchase global buyers.

CÔNG TY CỔ PHẦN SANOFI VIỆT NAM
ESKAY THERAPEUTICS LIMITED
PT HEXPHARM JAYA LABORATORIES
PROTEIN SA DE CV
CINCHONA BIOSCIENCES
KIMIA TRADING LTDA
ALPHAMED FORMULATIONS PRIVATE LIMITED
ANALYTICA CHEMIE INC
OPELLA HEALTHCARE INDIA PRIVATE LIMITED
SUMINISTROS ANALITICOS S A S
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
MARTIN DOW MARKER LIMITED
MEDIFARMA S A
REGAL PHARMACEUTICALS LIMITED
TATARASA PRIMATAMA
ARTZEN ZONDER GRENSEN HOLLAND MSF HOLLAND
CÔNG TY CỔ PHẦN DƯỢC ĐỒNG NAI
DAWA LIMITED
MEDVIN PHARMA LIMITED
PT IMCD INDONESIA
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
CÔNG TY CỔ PHẦN DƯỢC PHẨM CPC1 HÀ NỘI
CÔNG TY CỔ PHẦN DƯỢC PHẨM VĨNH PHÚC
AGLOBAL CARE INC
ASTRA PHARMA U LIMITED
CAISA PHARMA INTL
DISTRIMELL MJ S A
DROGUERIA INVERSIONES JPS SAC
ERNEST CHEMISTS LIMITED
FLAMINGO PHARMACEUTICALS LIMITED
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
MEDECINES SANS FRONTIERS SWITZERLAND
AMBICA INT L CORP
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
PT MERCK CHEMICALS LIFE SCIENCES
AE ALCHEMISTS INC
AGP LIMITED
CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED
CLIANTHA RESEARCH LIMITED
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
ESPECTROCROM CIA LTDA
HARLEYS LTD
INDUFAR COMERCIAL E INDUSTRIAL SA
LABADRIAN S E I R L
LABORATORIOS AC FARMA S A
LLOYD LABORATORIES INC
MHEDICAL PHARMA SRL
OLIVE PHARMASCIENCE LIMITED
PHARMA SURREY INTERNATIONAL INC
PHIL PHARMAWEALTH INC
PT IFARS PHARMACEUTICAL LABORATORIES
PT KALVENTIS SINERGI FARMA
RENIE CHEMIST LIMITED
SRI AMAN CORPORINDO PT
UNILAB INC
AMBICA INTERNATIONAL CORPORATION
ATABAY KIMYA SANAYI VE TICARET ANONIM SIRKETI
ATLANTIC LIFESCIENCES LIMITED
BOEHRINGER INGELHEIM PROMECO SA DE CV
CAMEG
CASA DE REPRESENTACION ZAKI CA
CONTROL TECNICO Y REPRESENTACIONES SA DE CV
CÔNG TY CỔ PHẦN HOÁ DƯỢC HIỆP LỰC
DEVA HOLDING ANONIM SIRKETI
DISTRIBUIDORA DANY S A C
DROGUERIA INTI S A
HABMAY PHARMACY LIMITED
IMPORTADORA MAE LABS SA DE CV
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
INTERPHIL LABORATORIES INC
KINAPHARMA LIMITED
LABS EXPOFARMA S A
LAQFAGAL FARMA INDUSTRIA S R L
M F TRADING SRLTDA
MARTIN DOW MARKER LTD
MERCK PERUANA S A
OQCORP SOCIEDAD ANONIMA CERRADA OQCORP S A C
PHARMA SURREY INT L INC
PRINCETON ENTERPRISES LIMITED
PT INTERBAT
QUALITYPHARMA S A S
QUIMICOS E INSUMOS INDUSTRIALES DE MEXICO SA DE CV
STATE PHARMACEUTICALS CORPORARION
SUNGLOW LIFESCIENCE PRIVATE LIMITED
TORRENT PHARMACEUTICALS LTD
ULTRA BIO INSTRUMENTS PRIVATE LIMITED
ULTRA INTERNATIONAL
UNIVERSAL TRADING AND SUPPLIES
WORLD MEDICINE ILAC SANAYI VE TICARET ANONIM SIRKETI
A NWAEZE PHARMACEUTICAL COMPANY LIMITED
AET LABORATORIES PRIVATE LIMITED
AMERICAN EMBASSY YAOUNDE
AMEX HEALTHCARE KENYA SEZ LIMITED
BELGIUM
BENDAHARA KHUSUS PUSKU TNI
BIOCKRODT PHARMA
CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED
CASA DE REPRESENTACION
CBM INTL FREIGHT S DE R L
CENTRAL CHEMICALS
CHI NHÁNH CÔNG TY TNHH GLANDCORE
CÔNG TY CỔ PHẦN DƯỢC PHẨM HÀ TÂY
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
DIGA LATAM S A
DRUGMAKERS LABORATORIES INC
EON PHARMATEK INC
EURO CARE PRODUCTS PHILIPPINES
FARMACOL CHINOIN S A S
GEORGE STEUART HEALTH PVT LTD
KALBE FARMA TBK
KEYFARM S A C
KHRIZ PHARMA TRADING INC
KRISHNA CHEMISTS LIMITED
LABMOL SAS
LABORATORIO CELTYC
LABORATORIOS CHALVER DE COLOMBIA SA
MDLD INTERCHEMICAL INDUSTRIES INC
MED HOUSE PHARMACEUTICAL LTD
MEDECINS SANS FRONTIERES
MEDROCK CORPORATION SOCIEDAD ANONIMA CERRADA
MERCK INC
MERCK LIFE SCIENCE PRIVATE LIMITED
MHEDICAL PHARMA
NUTRITION MARKET LTDA
ONG BAUTISTA DE DESARROLLO SOCIAL
OPELLA HEALTHCARE ARGENTINA S
OSONS CHEMIST LIMITED
PRO MED PHARMACEUTICALS LIMITED
PT ANUGERAH MENTARI DISTRINDO
PT BERNOFARM
ROSHANE PHARMA SARL
SABIHA RESEARCH AND DEVELOPMENT LLP
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
SIMSON PHARMA LIMITED
TEVA ILACLARI SANAYI VE TICARET ANONIM SIRKETI
UNICOM CHEMIST LIMITED
UNIQUE PHARMA
VICENTE SCAVONE CIA S A E
WINTHROP PHARMACEUTICALS DE COLOMBIA SA
ZAWADI HEALTHCARE LIMITED
A K PHARMACEUTICALS
A O TECH E I R L
AMIN PHARMACEUTICALS LIBERIA INC
APEX LABORATORIES PRIVATE LIMITED
ARGIS ILAC SANAYI VE TICARET ANONIM SIRKETI
ARICEL S A S
AUROBINDO PHARMA LIMITED
BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
BEXIMCO PHARMACEUTICALS LIMITED
BEXIMCO PHARMACEUTICALS PLC
BIORA GLOBAL LLP
BLUE MEDICAL PHARMACEUTICAL C A
BOEHRINGER INGELHEIM INDONESIA
CASA DE REPRESENTACION DISTRILAB C A
CASA DE REPRESENTACIONES
CCL PHARMACEUTICALS PVT LIMITED
CD
CEFARMA SA
CEYOKA PVT LTD
CHARPENTIER SRL
CHEMHUB TECHNOLOGIES INC
COMITE INTERNATIONAL DE LA CROIX ROUGE
COSMOS LIMITED
COSPHARM INVESTMENTS PTY LTD
CROWN SOLUTIONS LIMITED
CÔNG TY CỔ PHẦN DƯỢC VẬT TƯ Y TẾ HẢI DƯƠNG
CÔNG TY CỔ PHẦN DƯỢC VẬT TƯ Y TẾ THANH HOÁ
CÔNG TY TNHH MTV NOVALAB
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
CÔNG TY TNHH THƯƠNG MẠI QUỐC TẾ VHL
DALLAS S A
DHL KEELLS PVT LTD
DISTRIMELL M J SOCIEDAD ANONIMA
DISTRIMELL MJ SOCIEDAD ANONIMA
DISTRIMEMJ DISTRIMELL MJ S A
DROGUERIA LIPHARMA S A C
DRUGMAKER S LABORATORIES INC
EDRUC LIMITED
ESKAY THERAPEUTICS LTD
ESSENTIAL DRUGS CO LTD
ETS CARGO MALID
ETS CARGO MALID ADDRESS AV KAMINA Q MIKENO C DE GOMA GOMA D R CONGO CD
FLAMINGO PHARMACEUTICALS LTD
G2 PHARMACY
GENOME PHARMACEUTICALS PVT LIMITED
GENOME PHARMACEUTICALS PVT LTD
GREENANDES LOGISTICS SAC
GRUPO MULTILAB SOCIEDAD ANONIMA
GUTIS LIMITADA
HARMANN PHARMACEUTICALS PVT LTD
HEXAGON HEALTHCARE CORPORATION
IMPORTS DOS REIS S A
INDUSTRIAS REUNIDAS CIA LTDA INDUNIDAS LABORATORIOS INDUNIDAS
INSTITUTO QUIMIOTERAPICO S A
INTERNATIONAL COMMITTEE OF THE RED CROSS ICRC
JAVED CHEMICAL CORPORATION
KAMAZU PVT LTD
KARUNIA JASINDO
KRISHAT PHARMA INDUSTRIES LIMITED
KRISHPAR CARE BOLIVIA S R L
LABOMERSA S A
LABORATORIO RAVEN S A
LABORATORIO RAVEN SOCIEDAD ANONIMA
LABORATORIOS DELTA S A
LABORATORIOS PORTUGAL S R L
LABORATORIOS VITA S A
LETAP PHARMACEUTICALS LIMITED
LIFE PHARMACUTICAL CO
M G PHARMACEUTICALS LIMITED
MARKS CORPORATION
MARTIN DOW LIMITED
MAXITECH PHARMA PRIVATE LIMITED
MED PAL CHEMIST LIMITED
MEDECINS DU MONDE BELGIUM
MEDECINS SANS FRONTIERES FRANCE KENYA
MEDECINS SANS FRONTIERES MSF OCA HOLLAND
MEDECINS SANS FRONTIERS SWITZERLAND
MEDICAMENTOS CONSUMOS ASIA
MEMPHIS PRODUCTS S A
MERCK ALLYRISE INTERNATIONAL
MOLECULES ANALYTICAL LAB SOLUTIONS PRIVATE LIMITED
MOZART MEDICAL SUPPLIES CC NBOX
NAIROBI PHARMACEUTICALS KENYA LIMITED
NOVAPURE HEALTHCARE PRIVATE LIMITED
O VE R ORGANIZACION VETERINARIA REGIONAL SRL
OFFICE NATIONAL DES PRODUITS PHARMA
OMSYNTH LIFESCIENCES PRIVATE LIMITED
ON SHORE OFF SHORE SOLUTIONS GHANA LIMITED
PANACEA PHARMACEUTICAL LIMITED
PHARMACO HEALTHCARE LIMITED
PHARMAKON BIOTEC INC
PHARMANOVA LIMITED
PT BOEHRINGER INGELHEIM INDONESIA
PT MENJANGAN SAKTI
PT MERCK CHEMICALS AND LIFE SCIENCES
PT SANBE FARMA
PT SRI AMAN CORPORINDO
QUIMITRONICA SAS
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED
REDDYS PHARMA LIMITED
SANOFI ILAC SANAYI VE TICARET ANONIM SIRKETI
SARV BIO LABS PRIVATE LIMITED
SAVE THE CHILDREN SUDAN COUNTRY OFFICE
SHARAF SHIPPING AGENCY LIMITED
SIFA S A R L
SOLARIS LIFE SCIENCES PRIVATE LIMITED
SPAIN
SRI AMAN CORPORINDO
SS PREMIER MEDICAL SUPPLIES CC NP O BOX
SVIZERA LABS PRIVATE LIMITED
SWISS PHARMA GROUP S A
SYNOVIA PHARMA PLC CHANGED FROM
THE IBN SINA PHARMACEUTICAL
TIBA PANAMA S A
TLC WORLDWIDE S A
TLCWORLDWID TLC WORLDWIDE S A
UNICEF GOMA ANCIEN BATIMENT DE
V S INTERNATIONAL PRIVATE LIMITED
VDR DE MEXICO DISTRIBUCION SA DE CV
YGT LABORATUVAR CIHAZLARI SANAYI VE TICARET LIMITED SIRKETI

Conclusion

The global Hyoscine Butylbromide trade market features stable and growing demand, with verified professional buyers concentrated across Asia, Europe, Latin America, and Africa. This structured Hyoscine Butylbromide global buyers list covers core international importers, buyer category characteristics, and key procurement demands, providing targeted reference for pharmaceutical API exporters and drug formulation traders.

By aligning product quality, certification compliance, and market strategies with global buyer requirements, enterprises can efficiently develop high-quality international B2B partnerships and expand their global market share in the Hyoscine Butylbromide pharmaceutical trade industry.